Unique ID issued by UMIN | UMIN000006310 |
---|---|
Receipt number | R000007461 |
Scientific Title | Phase II study of early start of chemotherapy after excision of the primary colorectal cancer. (FUTURE 1102-Pearl star 02) |
Date of disclosure of the study information | 2011/09/20 |
Last modified on | 2019/05/23 16:09:02 |
Phase II study of early start of chemotherapy after excision of the primary colorectal cancer. (FUTURE 1102-Pearl star 02)
Phase II study of early start of chemotherapy after excision of the primary colorectal cancer. (FUTURE 1102-Pearl star 02)
Phase II study of early start of chemotherapy after excision of the primary colorectal cancer. (FUTURE 1102-Pearl star 02)
Phase II study of early start of chemotherapy after excision of the primary colorectal cancer. (FUTURE 1102-Pearl star 02)
Japan |
Colorectal Cancer
Gastrointestinal surgery |
Malignancy
NO
To evaluate the efficacy of the early start of chemotherapy after excision of the primary colorectal cancer.
Efficacy
Exploratory
Pragmatic
Phase II
Efficacy
Response rate
Time to treatment failure
Overall survival
Progression free survival
Safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Oxaliplatin 130mg/m2 i.v. (day1)
Bevaciumab 7.5mg/Kg i.v. (day1)
Capecitabine2,000mg/m2,p.o.(day1-14)
to be repeated every 3 weeks
20 | years-old | <= |
75 | years-old | >= |
Male and Female
1.Histologically confirmed colorectal cancer
2.Unresectable synchronous liver metastases
3.Resection of primary colorectal cancer
4.No prior chemotherapy and radiotherapy for colorectal cancer
5.Performance Status: 0-1 (ECOG criteria)
6.Age: 20 years to 75 years
7.Vital organ functions are preserved within 7 days prior to entry
WBC :>= 3,000 and =< 12,000/mm3
Neutrophil : >=1,500/mm3
Platelet : >= 100,000/mm3
T.bil.: <= 2.0 mg/dl
AST,ALT : <=100IU/l(in case of hepatic metastatic patients are <= 200IU/l)
Creatinin : <= 1.35mg/dl(female),1.80mg/dl(male)
8.Signed written informed consent
1.Prior severe drug allergy
2.Cavity fluid which needs drainage
3.Presence of active infection
4.Symptomatic brain metastases
5.Multiple malignancy within 5 years disease free interval
6.Uncontrolled hypertension
7.Uncontrolled diabetes
8.Peripheral nerve disorder
9.Severe pulmonary disease
10.Significant electrocardiographic abnormality
11.Treatment with anti-platelet drug
12.Chronic systemic treatment of corticosteroid
13.Nursing or pregnant females, or females or males with female partners who are planning to pregnancy
14.Inadequate for study enrollment by the physician
18
1st name | Yoichiro |
Middle name | |
Last name | Yoshida |
Fukuoka University School of Medicine
Department of Gastroenterological Surgery
814-0180
7-45-1,Nanakuma,Johnan-ku,Fukuoka ,814-0180,Japan
0928011011
yy4160@yahoo.co.jp
1st name | Yoichiro |
Middle name | |
Last name | Yoshida |
Fukuoka University School of Medicine
Gastroenterological Surgery
814-0180
7-45-1,Nanakuma,Johnan-ku,Fukuoka ,814-0180,Japan
0928011011
yy4160@yahoo.co.jp
Fukuoka Tumor Research(FUTURE)
None
Self funding
Fukuoka Univesity
7-45-1,Nanakuma
0928011011
yy4160@yahoo.co.jp
NO
福岡大学医学部消化器外科学
2011 | Year | 09 | Month | 20 | Day |
https://www.ncbi.nlm.nih.gov/pubmed/29863132
Published
https://www.ncbi.nlm.nih.gov/pubmed/29863132
18
https://www.ncbi.nlm.nih.gov/pubmed/29863132
2019 | Year | 05 | Month | 23 | Day |
Same as above
Same as above
Same as above
Same as above
Completed
2011 | Year | 06 | Month | 01 | Day |
2011 | Year | 08 | Month | 21 | Day |
2011 | Year | 09 | Month | 01 | Day |
2015 | Year | 12 | Month | 31 | Day |
2011 | Year | 09 | Month | 08 | Day |
2019 | Year | 05 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007461